PHARMATHENE, INC 4

Accession 0001144204-16-136387

$ALTCIK 0001326190operating

View on SEC.gov Company Profile

Filed

Nov 22, 7:00 PM ET

Accepted

Nov 23, 4:47 PM ET

Size

39.4 KB

Accession

0001144204-16-136387

Insider Transaction Report

Form 4

Period: 2016-11-22

PHARMATHENE, INCPIP

SAYARE MITCHEL

Director

Transactions

Exercise/Conversion
Common Stock, $0.0001 par value per share
2016-11-22$1.60/sh+20,000$32,000→ 45,000 total
Exercise/Conversion
Common Stock, $0.0001 par value per share
2016-11-22$1.69/sh+20,000$33,800→ 255,500 total
Exercise/Conversion
Common Stock, $0.0001 par value per share
2016-11-22$1.81/sh+18,361$33,233→ 235,500 total
Exercise/Conversion
Stock option (right to buy)
2016-11-22−20,000→ 0 total
Exercise: $2.20From: 2017-06-01Exp: 2026-05-31→ Common Stock (20,000 underlying)
Exercise/Conversion
Common Stock, $0.0001 par value per share
2016-11-22$2.67/sh+52,139$139,211→ 157,139 total
Exercise/Conversion
Stock option (right to buy)
2016-11-22−20,000→ 0 total
Exercise: $1.60From: 2010-06-23Exp: 2020-06-23→ Common Stock (20,000 underlying)
Exercise/Conversion
Stock option (right to buy)
2016-11-22−18,361→ 0 total
Exercise: $1.81From: 2014-12-31Exp: 2024-12-31→ Common Stock (18,361 underlying)
Exercise/Conversion
Common Stock, $0.0001 par value per share
2016-11-22$1.52/sh+20,000$30,400→ 25,000 total
Exercise/Conversion
Common Stock, $0.0001 par value per share
2016-11-22$1.64/sh+20,000$32,800→ 197,139 total
Exercise/Conversion
Common Stock, $0.0001 par value per share
2016-11-22$2.20/sh+20,000$44,000→ 275,500 total
Exercise/Conversion
Stock option (right to buy)
2016-11-22−60,000→ 0 total
Exercise: $2.67From: 2011-07-15Exp: 2021-07-15→ Common Stock (60,000 underlying)
Exercise/Conversion
Stock option (right to buy)
2016-11-22−20,000→ 0 total
Exercise: $1.45From: 2013-06-22Exp: 2022-06-22→ Common Stock (20,000 underlying)
Exercise/Conversion
Common Stock, $0.0001 par value per share
2016-11-22$1.45/sh+20,000$29,000→ 177,139 total
Exercise/Conversion
Common Stock, $0.0001 par value per share
2016-11-22$1.51/sh+20,000$30,200→ 217,139 total
Exercise/Conversion
Stock option (right to buy)
2016-11-22−20,000→ 0 total
Exercise: $1.52From: 2010-04-27Exp: 2020-04-27→ Common Stock (20,000 underlying)
Exercise/Conversion
Stock option (right to buy)
2016-11-22−52,139→ 0 total
Exercise: $2.67From: 2011-10-15Exp: 2021-07-17→ Common Stock (52,139 underlying)
Exercise/Conversion
Stock option (right to buy)
2016-11-22−20,000→ 0 total
Exercise: $1.64From: 2014-06-11Exp: 2023-06-11→ Common Stock (20,000 underlying)
Exercise/Conversion
Stock option (right to buy)
2016-11-22−20,000→ 0 total
Exercise: $1.51From: 2015-06-18Exp: 2024-06-17→ Common Stock (20,000 underlying)
Exercise/Conversion
Stock option (right to buy)
2016-11-22−20,000→ 0 total
Exercise: $1.69From: 2016-08-02Exp: 2025-08-01→ Common Stock (20,000 underlying)
Exercise/Conversion
Common Stock, $0.0001 par value per share
2016-11-22$2.67/sh+60,000$160,200→ 105,000 total

Documents

1 file

4
v453826_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

PHARMATHENE, INC

CIK 0001326190

→

Entity typeoperating

IncorporatedDE

Related Parties

filerCIK 0001326190

Filing Metadata

Form type: 4
Filed: Nov 22, 7:00 PM ET
Accepted: Nov 23, 4:47 PM ET
Size: 39.4 KB

View on SEC.gov